trial · primary record
Intensity-Modulated Radiation Therapy
Astrocytoma, IDH-Mutant, Grade 3
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 408 |
| Primary completion | 2040-01 |
| Primary endpoint | Progression free survival (PFS) by blinded independent central review (BICR) |
| Registry ID | NCT07215910 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:32.149Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07215910
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.